# Galectin Therapeutics Inc: Form 8-K, filed Mar 5, 2025

- Company: [Galectin Therapeutics Inc](/companies/galt.md) (CIK 1133416)
- Form: 8-K
- Filed: 2025-03-05
- Accepted by EDGAR: Mar 5, 2025, 13:00 ET
- Period: 2025-03-05
- Accession: 0001140361-25-007063
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1133416/000114036125007063/ef20044880_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1133416/000114036125007063/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1133416/000114036125007063/ef20044880_8k.htm

Filed Mar 5, 2025.
Source: SEC EDGAR, the filing index for accession 0001140361-25-007063. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.